Novel compounds and uses thereof

Details for Australian Patent Application No. 2003295157 (hide)

International Classifications

Event Publications

22 April 2004 Complete Application Filed

Priority application(s): 0229742.2 23.12.02 GB

19 August 2004 Application Open to Public Inspection

Published as AU-B-2003295157

25 August 2005 Corrigenda

Applications OPI - Name Index Under the name DESTINY PHARMA LIMITED, Application No. 2003295157, under INID (71) correct the name to read Destiny Pharma Limited; Solvias AG.

28 October 2010 Application Accepted

Published as AU-B-2003295157

2 December 2010 Corrigenda

Applications Accepted - Name Index Under the name Destiny Pharma Limited; Solvias AG, Application No. 2003295157, under INID (54) correct the title to read Cationic Porphyrin Derivatives as Antibacterial Agents

24 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.